Shionogi & Co., Ltd. (Head Office: Osaka; President: Isao Teshirogi; hereafter “Shionogi”) today announced that its U.S.-based group company, Sciele Pharma, Inc. (hereafter “Sciele”), and two group companies have changed their company names as detailed below.
1. New Company Name (old company names are shown in parentheses)
(1) Shionogi Pharma, Inc. (Sciele Pharma, Inc.)
(2) Shionogi Pharma Sales, Inc. (Sciele Pharma Sales, Inc.)
(3) Shionogi Ireland Ltd. (Sciele Pharma Ireland Ltd.)
Read More: http://www.gabio.org/pr_details.aspx?subid=285&refid=8
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment